CryoLife Shares Plunge on FDA Order
- Share via
Reuters
Shares of CryoLife Inc., which collects and freezes human tissue for transplant, tumbled 63% a day after U.S. regulators said they ordered the company to recall and halt sales of most of its processed tissue because of safety concerns.
After being halted early Thursday, shares of CryoLife closed down $3.49 at $2.03 on the NYSE. .
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
